切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2020, Vol. 13 ›› Issue (06) : 432 -438. doi: 10.3877/cma.j.issn.1674-6880.2020.06.006

所属专题: 文献

论著

无创心排血量监测联合重症超声在急性呼吸窘迫综合征患者中的临床应用
彭相虹1, 廖诚德2, 叶冰洁1, 张莉1, 宋志1,()   
  1. 1. 518055 深圳,深圳大学总医院重症医学科
    2. 518052 深圳,华中科技大学协和深圳医院超声科
  • 收稿日期:2020-06-29 出版日期:2020-12-31
  • 通信作者: 宋志
  • 基金资助:
    深圳大学总医院科技人才助推计划项目(SUGH2019QD002)

Clinical application of noninvasive cardiac output monitoring combined with severe ultrasound in patients with acute respiratory distress syndrome

Xianghong Peng1, Chengde Liao2, Bingjie Ye1, Li Zhang1, Zhi Song1,()   

  1. 1. Department of Intensive Care Unit, Shenzhen University General Hospital, Shenzhen 518055, China
    2. Department of Ultrasound, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen 518052, China
  • Received:2020-06-29 Published:2020-12-31
  • Corresponding author: Zhi Song
引用本文:

彭相虹, 廖诚德, 叶冰洁, 张莉, 宋志. 无创心排血量监测联合重症超声在急性呼吸窘迫综合征患者中的临床应用[J/OL]. 中华危重症医学杂志(电子版), 2020, 13(06): 432-438.

Xianghong Peng, Chengde Liao, Bingjie Ye, Li Zhang, Zhi Song. Clinical application of noninvasive cardiac output monitoring combined with severe ultrasound in patients with acute respiratory distress syndrome[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(06): 432-438.

目的

探讨无创心排血量监测(NICOM)联合重症超声在急性呼吸窘迫综合征(ARDS)患者液体管理中的应用效果。

方法

选取深圳大学总医院2018年7月至2020年2月收治的126例ARDS患者,将其分为研究组(63例)和对照组(63例)。对照组采用传统的血流动力学监测方法指导液体管理治疗;研究组在对照组的基础上,采用NICOM联合重症超声评估指导液体管理治疗。比较两组患者的一般资料、呋塞米、液体入量、液体出量以及治疗7 d后肺损伤评分、氧合指数、动脉血二氧化碳分压、动脉血pH值、中心静脉血氧饱和度、B线计数、血肌酐、血尿素氮、血红蛋白、碳酸氢盐、血糖水平及预后情况。

结果

研究组患者应用呋塞米[(47.0 ±3.5)mg / d vs.(21.6 ± 2.3)mg / d,t = 48.035,P < 0.001]、液体出量[(3 332 ± 106)mL / d vs.(2 862 ± 100)mL / d,t = 25.485,P < 0.001]、氧合指数[(327.3 ± 3.5)mmHg vs.(203.4 ± 2.6)mmHg,t = 225.002,P < 0.001]、中心静脉血氧饱和度[(77 ± 22)% vs.(67 ± 19)%,t = 2.847,P = 0.005]、血红蛋白[(91.0 ±1.8)g / L vs.(87.0 ± 1.8)g / L,t = 12.369,P < 0.001]、28 d内脱离呼吸机时间[(15.1 ± 0.5)d vs.(11.5 ± 0.6)d,t = 36.634,P < 0.001]均显著高于对照组,而液体入量[(3 162 ± 90)mL / d vs.(3 837 ±120)mL / d,t = 35.693,P < 0.001]、肺损伤评分[(2.79 ± 0.30)分vs.(4.70 ± 0.20)分,t = 41.912,P < 0.001]、B线计数[(9 ± 4)个vs.(12 ± 4)个,t = 4.458,P < 0.001]、血糖[(7.9 ± 0.3)mmol / L vs.(8.0 ± 0.4)mmol / L,t = 2.758,P = 0.007]及ICU住院时间[(17.5 ± 1.8)d vs.(21.7 ± 2.3)d,t = 11.435,P < 0.001]均显著低于对照组。对照组及研究组患者28 d病死率[27.0%(17 / 63) vs. 17.5%(11 / 63)]和28 d内器官功能障碍发生率[41.3%(26 / 63) vs. 44.4%(28 / 63)]比较,差异均无统计学意义( χ2 = 1.653、0.130,P = 0.199、0.719)。

结论

通过NICOM联合重症超声对ARDS患者的容量进行管理,可以改善ARDS患者肺部氧合情况,减少液体入量,明显缩短住ICU时间及机械通气时间,并不增加器官功能障碍,值得临床推广。

Objective

To investigate the effect of noninvasive cardiac output monitoring (NICOM) combined with severe ultrasound in fluid management of patients with acute respiratory distress syndrome (ARDS).

Methods

From July 2018 to February 2020, 126 patients with ARDS admitted to Shenzhen University General Hospital were divided into a study group (n = 63) and a control group (n = 63). Traditional hemodynamic monitoring methods were used to guide fluid management in the control group, while in the study group, the NICOM combined with severe ultrasound evaluation were used on the basis of the control group. The general data, furosemide use, fluid intake, fluid output and prognosis were compared between these two groups, as well as the lung injury score, oxygenation index, arterial blood carbon dioxide partial pressure, arterial blood pH value, central venous oxygen saturation, B line count, blood creatinine, blood urea nitrogen, hemoglobin, bicarbonate and blood glucose after 7 days of treatment.

Results

The furosemide use [(47.0 ± 3.5) mg / d vs. (21.6 ± 2.3) mg / d, t = 48.035, P < 0.001], fluid output [(3 332 ± 106) mL / d vs. (2 862 ± 100) mL / d, t = 25.485, P < 0.001], oxygenation index [(327.3 ± 3.5) mmHg vs. (203.4 ± 2.6) mmHg, t = 225.002, P < 0.001], central venous oxygen saturation [(77 ± 22)% vs. (67 ± 19)%, t = 2.847, P = 0.005], hemoglobin [(91.0 ± 1.8) g / L vs. (87.0 ± 1.8) g / L, t = 12.369, P < 0.001], ventilator weaning within 28 d [(15.1 ± 0.5) d vs. (11.5 ± 0.6) d, t = 36.634, P < 0.001] in the study group were significantly higher than those in the control group. The fluid intake [(3 162 ± 90) mL / d vs. (3 837 ± 120) mL / d, t = 35.693, P < 0.001], lung injury score [(2.79 ± 0.30) vs. (4.70 ± 0.20), t = 41.912, P < 0.001], B line count [(9 ± 4) vs. (12 ± 4), t = 4.458, P < 0.001], blood glucose [(7.9 ± 0.3) mmol / L vs. (8.0 ± 0.4) mmol / L, t = 2.758, P = 0.007] and ICU stay [(17.5 ± 1.8) d vs. (21.7 ± 2.3) d, t = 11.435, P < 0.001] in the study group were significantly lower than those in the control group. There were no significant differences in the 28-d mortality [27.0% (17 / 63) vs. 17.5% (11 / 63)] and incidence of organ dysfunction within 28 d [41.3% (26 / 63) vs. 44.4% (28 / 63)] between the control group and study group ( χ2 = 1.653, 0.130; P = 0.199, 0.719).

Conclusion

The fluid management of ARDS patients by NICOM combined with severe ultrasound can improve their pulmonary oxygenation, reduce fluid intake and significantly shorten the duration of ICU stay and mechanical ventilation without increasing organ dysfunction, which is worth promotion in clinic.

表1 两组ARDS患者一般资料比较( ±s
表2 两组ARDS患者应用呋塞米、液体摄入、液体输出和液体平衡情况比较( ±s
表3 两组ARDS患者治疗后平均动脉压、中心静脉压及血管活性药物应用情况比较( ±s
表4 两组ARDS患者治疗后肺损伤评分、血气分析指标及B线计数比较( ±s
表5 两组ARDS患者治疗后血尿素氮、血肌酐、碳酸氢盐、血红蛋白及血糖水平比较( ±s
表6 两组ARDS患者预后情况比较( ±s
1
Slutsky AS, Villar J, Pesenti A. Happy 50th birthday ARDS![J]. Intensive Care Med, 2016, 42 (5): 637-639.
2
杨茂宪,赵文静,王丽燕,等. 驱动压对肺内源性急性呼吸窘迫综合征的影响[J/CD]. 中华危重症医学杂志(电子版),2018,11(4):238-243.
3
严一核,孙雪东,李智鑫,等. 急性呼吸窘迫综合征患者肺泡微环境对肺成纤维细胞生物学活性的影响[J/CD]. 中华危重症医学杂志(电子版),2018,11(3):151-156.
4
周垒垒,张先明. 急性呼吸窘迫综合征的发病机制及临床前药物研究[J]. 中华危重病急救医学,2020,32(3):378-381.
5
Xu B, Chen SS, Liu MZ, et al. Stem cell derived ex-osomes-based therapy for acute lung injury and acute respiratory distress syndrome: a novel therapeutic strategy[J]. Life Sci, 2020 (254): 117766.
6
Ervin JN, Rentes VC, Dibble ER, et al. Evidence-ba-sed practices for acute respiratory failure and acute respiratory distress syndrome: a systematic review of reviews[J]. Chest, 2020, 158 (6): 2381-2393.
7
刘大为,王小亭,张宏民,等. 重症血流动力学治疗——北京共识[J]. 中华内科杂志,2015,54(3):248-271.
8
丁欣,王小亭,张宏民,等. 中国重症超声专家共识解读[J]. 中国实用内科杂志,2017,37(5):434-436.
9
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. JAMA, 2012, 307 (23): 2526-2533.
10
高秋芳,高洪媛,屈峰. 床旁B超在脓毒性休克合并急性呼吸窘迫综合征中的应用[J/CD]. 中华危重症医学杂志(电子版),2018,11(5):338-341.
11
Kaku S, Nguyen CD, Htet NN, et al. Acute res-piratory distress syndrome: etiology, pathogenesis, and summary on management[J]. J Intensive Care Med, 2020, 35 (8): 723-737.
12
曹关义,李泉,朱红岩,等. 脉波轮廓温度稀释连续心排量测量技术在重症急性胰腺炎合并急性呼吸道窘迫综合征患者液体管理中的应用[J/CD]. 中华危重症医学杂志(电子版),2016,9(2):96-100.
13
Saguil A, Fargo MV. Acute respiratory distress syndr-ome: diagnosis and management[J]. Am Fam Physician, 2020, 101 (12): 730-738.
14
Seitz KP, Caldwell ES, Hough CL. Fluid management in ARDS: an evaluation of current practice and the association between early diuretic use and hospital mortality[J]. J Intensive Care, 2020 (8): 78.
15
Vignon P, Evrard B, Asfar P, et al. Fluid adminis-tration and monitoring in ARDS: which management?[J]. Intensive Care Med, 2020, 46 (12): 2252-2264.
16
Hansen KS, Honge BL, Ommen HB, et al. Successful use of extracorporeal membrane oxygenation in respiratory failure due to influenza and acute myeloid leukemia[J]. Int J Infect Dis, 2020 (96): 570-572.
17
许瑞玉. 血管外肺水联合中心静脉血氧饱和度监测在急性呼吸窘迫综合征患者液体管理中的应用效果[J]. 临床合理用药杂志,2020,13(12):11-13.
18
Ma S, Zhao ML, Wang K, et al. Association of Ang-2, vWF, and EVLWI with risk of mortality in sepsis patients with concomitant ARDS: a retrospective study[J]. J Formos Med Assoc, 2020, 119 (5): 950-956.
19
金光勇,林乐清,梁栋诚,等. 全心舒张末期容积指数对心功能不全并脓毒性休克患者液体复苏的应用价值[J/CD]. 中华危重症医学杂志(电子版),2018,11(6):377-381.
20
Preau S, Bortolotti P, Colling D, et al. Diagnostic ac-curacy of the inferior vena cava collapsibility to predict fluid responsiveness in spontaneously breathing patients with sepsis and acute circulatory failure[J]. Crit Care Med, 2017, 45 (3): e290-e297.
21
Pereira RM, Silva AJLCD, Faller J, et al. Comparative analysis of the collapsibility index and distensibility index of the inferior vena cava through echocardiography with pulse pressure variation that predicts fluid responsiveness in surgical patients: an observational controlled trial[J]. J Cardiothorac Vasc Anesth, 2020, 34 (8): 2162-2168.
22
Seibel A, Zechner PM, Berghold A, et al. B-Lines for the assessment of extravascular lung water: just focused or semi-quantitative?[J]. Acta Anaesthesiol Scand, 2020, 64 (7): 953-960.
[1] 江雅婷, 刘林峰, 沈辰曦, 陈奔, 刘婷, 龚裕强. 组织相关巨噬素3 保护肺血管内皮糖萼治疗急性呼吸窘迫综合征的机制研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 353-362.
[2] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[3] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[4] 李先锋, 何懿, 程贞永, 邓国魁, 胡波, 谢红, 王莉, 王小燕, 李晓明. 右美托咪定对腹腔镜腹股沟疝修补术患者血流动力学及麻醉复苏效果的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 437-441.
[5] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[6] 王守森, 傅世龙, 鲜亮, 林珑. 深入理解控制性减压技术对创伤性颅脑损伤术中脑膨出的预防机制与效果[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 257-262.
[7] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[8] 杨东星, 沈鹏, 赵慧颖. 免疫球蛋白联合依库珠单抗治疗GBS 并发重度ARDS 患者一例[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 404-408.
[9] 倪韫晖, 杨毅, 袁雪燕, 邱海波. 胸壁加压在急性呼吸窘迫综合征中的应用和临床进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 243-247.
[10] 杨永红, 杨莹, 齐红蕾, 刘福瑞, 朱金源. 单细胞测序在急性呼吸窘迫综合征中的应用进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 248-252.
[11] 李松栗, 黄蔚, 巢杰, 杨毅, 邱海波. 单核/巨噬细胞来源的细胞外囊泡在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 253-257.
[12] 田学, 谢晖, 王瑞兰. 急性呼吸窘迫综合征相关肺纤维化的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 258-264.
[13] 谢浩文, 丁建英, 刘小霞, 冯毅, 姚婧. 椎旁神经阻滞对微创胃切除肥胖患者术中血流、术后应激及康复质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 569-573.
[14] 刘聪辉, 何浩然, 黄一诺, 张凤, 王凡月, 郝翰. 膳食铜补充对大鼠心肌梗死后心肌基质金属蛋白酶2表达水平及血流动力学的影响[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 166-172.
[15] 芦乙滨, 李梦蝶, 许明. PDCA(计划、执行、检查和处理)循环教学在内科住院医师重症超声指导血流动力学评估培训中的效果评价[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 224-228.
阅读次数
全文


摘要